-- 5N Plus（VNP.TO）周一宣布任命阿尔班·富尼耶（Alban Fournier）为首席财务官，该任命将于4月27日生效。这是该公司此前公布的领导层继任计划的一部分，根据该计划，现任首席财务官理查德·佩隆（Richard Perron）将出任总裁兼首席执行官，现任首席执行官热尔韦·雅克（Gervais Jacques）将出任董事会执行主席，该任命将于5月31日生效。 该公司表示，富尼耶拥有近30年在三大洲担任企业和运营职务的经验，最近曾任蒙特利尔港务局首席财务官兼首席技术官，并负责采购工作。 该公司股票上周五在多伦多证券交易所收盘上涨4.2%，至35.47加元。
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF